Prostaglandins and the epithelial response to radiation injury in the intestine

Current Opinion in Gastroenterology

Volumn 20, Issue 2, 2004, Pages 61-64

  Stenson, William F ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16,16 DIMETHYLPROSTAGLANDIN E2; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; G PROTEIN COUPLED RECEPTOR; INDOMETACIN; INTERLEUKIN 1; INTERLEUKIN 11; LIPOPOLYSACCHARIDE; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN E2; RADIOPROTECTIVE AGENT; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CELL SURVIVAL; DNA DAMAGE; DNA REPAIR; DRUG MECHANISM; EDITORIAL; INTESTINE EPITHELIUM CELL; INTESTINE INJURY; IONIZING RADIATION; MUTATION; NONHUMAN; RADIATION; RADIATION INJURY; RADIATION PROTECTION; STEM CELL;

EID: 1542380059     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200403000-00002     Document Type: Editorial

References (42)

1. Gordon JI, Hermiston ML: Differentiation and self-renewal in the mouse gastrointestinal epithelium. Curr Opin Cell Biol 1994, 6:795-803.
2. Cheng H, Leblond CP: Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian theory of the origin of the four epithelial cell types. Am J Anat 1994, 141:537-561.
3. Cohn SM, Simon TC, Roth KA, et al.: Use of transgenic mice to map cis-acting elements in the intestinal fatty acid binding protein gene (Fabpi) that controls its cell lineage-specific and regional patterns of expression along the duodenal-colonic and crypt-villus axes of the gut epithelium. J Cell Biol 1992, 119:27-44.
4. Schmidt GH, Wilkinson MM, Ponder BAJ: Cell migration pathway in the intestinal epithelium: an in situ marker system using mouse aggregation chimeras. Cell 1985, 40:425-429.
5. Winton DJ, Ponder BA: Stem-cell organization in mouse small intestine. Proc R Soc Lond B Biol Sci 1990, 241:13-18.
6. Potten CS, Loeffler M: Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990, 110:1001-1020.
7. Potten CS, Loeffler M: A comprehensive model of the crypts of the small intestine of the mouse provides insight into the mechanisms of cell migration and the proliferation hierarchy. J Theor Biol 1987, 127:381-391.
8. Potten CS: A comprehensive study of the radiobiological response of the murine (BDFI) small intestine. Int J Radiat Biol 1990, 58:925-973.
9. Withers HR, Elkind MM: Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int J Radiat Biol 1987, 117:261-267.
10. Maisin JR: Bacq and Alexander Award Lecture. Chemical radioprotection: past, present and future prospects. Int J Radiat Biol 1998, 73:443-450.
11. Wu SG, Miyamoto T: Radioprotection of the intestinal crypts of mice by recombinant human interleukin-1α. Radiat Res 1990, 123:112-115.
12. Potten CS: Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pretreatment with interleukin 11 also increases murine survival time. Stem Cells 1996, 14:452-459.
13. Potten CS, Booth D, Haley JD: Pretreatment with transforming growth factor beta-3 protects small intestinal stem cells against radiation damage in vivo. Br J Cancer 1997, 75:1454-1459.
14. Hanson WR, DeLaurentiis K: Comparison of in vivo murine intestinal radiation protection by E-prostaglandins. Prostaglandins 1987, 33(suppl):93-104.
15. 2 increases survival of murine intestinal stem cells when given before photon radiation. Radiat Res 1983, 96:393-398.
16. 2 induces radio-protection in murine intestinal and hematopoietic stem cells. Radiat Res 1985, 103:196-203.
17. Eberhart CE, Dubois RN: Eicosanoids and the gastrointestinal tract. Gastroenterology 1995, 109:285-301.
18. Herschman HR: Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev 1994, 13:241-256.
19. Cohn SM, Schloemann S, Tessner T, et al.: Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J Clin Invest 1997, 99:1367-1379.
20. DuBois RN, Radhika A, Reddy BS, et al.: Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 1996, 110:1259-1262.
21. Eberhart CE, Coffey RJ, Radhika A, et al.: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994, 107:1183-1188.
22. Singer II, Kawaka DW, Schloemann S, et al: Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 1998, 115:297-306.
23. Seibert K, Masferrer J, Zhang Y, et al.: Mediation of inflammation by cyclooxygenase-2. Agents Actions Suppl 1995, 46:41-50.
24. Shattuck-Brandt RL, Varilek GW, Radhika A, et al.: Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice. Gastroenterology 2000, 118:337-345.
25. Newberry RD, Stenson WF, Lorenz RG: Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat Med 1999, 5:900-906.
26. 2 production by stromal cells in the murine small intestine lamina propria: Directing the tone of the intestinal immune response. J Immunol 2001, 166:4465-4472.
27. Hawkey CJ, Rampton DS: Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease or treatment? Gastroenterology 1985, 89:1162-1188.
28. Tsujii M, Dubois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995, 83:493-501.
29. Chulada PC, Thompson MB, Mahler JF, et al.: Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res 2000, 60:4705-4708.
30. Riehl T, Cohn S, Tessner T, et al.: Lipopolysaccharide is radioprotective in the mouse intestine through a prostaglandin-mediated mechanism. Gastroenterology 2000, 118:1106-1116.
31. Houchen CW, Stenson WF, Cohn SM: Disruption of cyclooxygenase-1 gene results in an impaired response to radiation injury. Am J Physiol Gastrointest Liver Physiol 2000, 279:G858-G865.
32. Riehl TE, Newberry RD, Lorenz RG, et al.: Tumor necrosis factor receptor 1 (TNFR1) mediates the radioprotective effects of lipopolysaccharide in the mouse intestine. Am J Physiol Gastrointest Liver Physiol 2004, 286:166-173.
33. Tessner TG, Muhale F, Schloemann S, et al.: Ionizing radiation upregulates cyclooxygenase-2 in 1407 cells through p38 mitogen-activated protein kinase. Carcinogenesis 2004, 25:37-45.
34. Abramovitz M, Adam M, Boie Y, et al.: The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta 2000, 1483:285-293.
35. Coleman RA, Smith WL, Narumiya S: International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994, 46:205-229.
36. Narumiya S, Sugimoto Y, Ushikubi F: Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999, 79:1193-1226.
37. Pierce KL, Gil DW, Woodward DF, et al.: Cloning of human prostanoid receptors. Trends Pharmacol Sci 1995, 16:253-256.
38. 2 receptor in intestine. Am J Physiol Gastrointest Liver Physiol 2003, 284:G490-G498.
39. Bjarnason I, Zanelli G, Smith T, et al.: Nonsteroidal anti-inflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1998, 93:480-489.
40. Tanaka A, Hase S, Miyazawa T, et al.: Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: Relation to various pathogenic events. J Pharmacol Exp Ther 2002, 303:1248-1254.
41. Krajewski S, Krajewska M, Shabaik A, et al.: Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 1994, 145:1323-1336.
42. Merritt AJ, Potten CS, Watson AJM, et al.: Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci 1995, 108:2261-2271.